The Ryman board has determined that it is in the best interests of the company to suspend dividends as the business goes through a reset; working to improve operating cash flows, completing delayed capital-intensive main buildings, maintaining prudent financial headroom and determining a cadence and financial envelope for future build rates. The current intention is to undertake a review of the dividend policy at FY26. Any future dividend policy is expected to be based on cash flow.
Ryman adopted a Dividend Reinvestment Plan in November 2022.
The plan provides shareholders with the opportunity to reinvest all or part of their dividends in additional Ryman Healthcare Limited shares, free of brokerage and other transaction costs, at a 2.5 percent discount to market price at the time entitlements are determined.
The Dividend Reinvestment Plan will be effective for the dividend payable in respect of the six-month period ended 30 September 2022. Participation elections, once given, apply to all future dividends, unless updated. The Board has discretion to suspend or terminate the Plan.
The Dividend Reinvestment Plan Offer Document dated November 2022 is available to download below.